Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00934947 · ClinicalTrials.gov registry record · Phase 2
Burn Healing and Analgesia With Propranolol
A Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT00934947 is a Phase 2 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 45 participants.
The verdict
NCT00934947, a Phase 2 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the ability of propranolol to decrease pain and improve recovery in burn patients with a common genotype.
Interventions
- DRUG Placebo
- DRUG Propranolol
- DRUG Propanolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00934947
The ClinicalTrials.gov registry entry for NCT00934947 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00934947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00934947 about?
NCT00934947 is a clinical study titled "Burn Healing and Analgesia With Propranolol". The purpose of this study is to investigate the ability of propranolol to decrease pain and improve recovery in burn patients with a common genotype.
What is the current status of trial NCT00934947?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2009-07. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00934947?
The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG), Propanolol (DRUG).
Who is sponsoring clinical trial NCT00934947?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.